U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Substance Class Protein
Created
by admin
on Sat Dec 16 11:34:26 UTC 2023
Edited
by admin
on Sat Dec 16 11:34:26 UTC 2023
Protein Type RECEPTOR
Protein Sub Type
Sequence Origin HUMAN
Sequence Type COMPLETE
Record UNII
50U1BO5G5P
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ALPHA-2A ADRENERGIC RECEPTOR
Common Name English
alpha2A
Common Name English
ALPHA-2AAR
Common Name English
ALPHA-2A ADRENORECEPTOR
Common Name English
ALPHA-2 ADRENERGIC RECEPTOR SUBTYPE C10
Common Name English
ADRA2A
Common Name English
Code System Code Type Description
PHAROS
P08913
Created by admin on Sat Dec 16 11:34:27 UTC 2023 , Edited by admin on Sat Dec 16 11:34:27 UTC 2023
PRIMARY
WIKIPEDIA
ALPHA-2_ADRENERGIC_RECEPTOR#INDIVIDUAL
Created by admin on Sat Dec 16 11:34:27 UTC 2023 , Edited by admin on Sat Dec 16 11:34:27 UTC 2023
PRIMARY
FDA UNII
50U1BO5G5P
Created by admin on Sat Dec 16 11:34:27 UTC 2023 , Edited by admin on Sat Dec 16 11:34:27 UTC 2023
PRIMARY
UNIPROT
P08913
Created by admin on Sat Dec 16 11:34:27 UTC 2023 , Edited by admin on Sat Dec 16 11:34:27 UTC 2023
PRIMARY
From To
1_106 1_188
Glycosylation Type HUMAN
Glycosylation Link Type Site
N 1_10
N 1_14
Related Record Type Details
Structure of OXYMETHOLONE
AGONIST -> TARGET
Structure of XYLAZINE
AGONIST -> TARGET
SHORT-ACTING
Structure of CIRAZOLINE
INHIBITOR -> TARGET
Ki
Structure of LURASIDONE
AGONIST -> TARGET
SHORT-ACTING
Structure of ZOTEPINE
AGONIST -> TARGET
SHORT-ACTING
Structure of RILMENIDINE
AGONIST -> TARGET
SHORT-ACTING
Structure of TOLAZOLINE
AGONIST -> TARGET
SHORT-ACTING
Structure of OLANZAPINE
AGONIST -> TARGET
SHORT-ACTING
Structure of EFAROXAN
AGONIST -> TARGET
SHORT-ACTING
Structure of GUANFACINE
AGONIST -> TARGET
SHORT-ACTING
Structure of IDAZOXAN
AGONIST -> TARGET
SHORT-ACTING
Structure of DETOMIDINE
AGONIST -> TARGET
SHORT-ACTING
Structure of DROXIDOPA
AGONIST -> TARGET
Structure of XYLOMETAZOLINE
AGONIST -> TARGET
SHORT-ACTING
Structure of 4-METHOXYAMPHETAMINE
AGONIST -> TARGET
Structure of TASIPIMIDINE
AGONIST -> TARGET
Structure of ROTIGOTINE
AGONIST -> TARGET
SHORT-ACTING
Structure of TALIPEXOLE
AGONIST -> TARGET
SHORT-ACTING
Structure of SETIPTILINE
AGONIST -> TARGET
SHORT-ACTING
Structure of YOHIMBINE C-11
RADIOLIGAND->TARGET
Structure of AGMATINE
AGONIST -> TARGET
SHORT-ACTING
Structure of BRIMONIDINE
AGONIST -> TARGET
SHORT-ACTING
Structure of TIZANIDINE
AGONIST -> TARGET
SHORT-ACTING
Structure of TIAMENIDINE
AGONIST -> TARGET
SHORT-ACTING
Structure of BENZPHETAMINE
AGONIST -> TARGET
Structure of APRACLONIDINE
AGONIST -> TARGET
SHORT-ACTING
Structure of EPINEPHRINE
AGONIST -> TARGET
SHORT-ACTING
Structure of MEDETOMIDINE
AGONIST -> TARGET
SHORT-ACTING
Structure of Povafonidine
ACTIVATOR -> TARGET
Structure of MELPERONE
AGONIST -> TARGET
SHORT-ACTING
Structure of MIRTAZAPINE
AGONIST -> TARGET
SHORT-ACTING
Structure of MIVAZEROL
AGONIST -> TARGET
SHORT-ACTING
Structure of CENTHAQUINE
INHIBITOR -> TARGET
Structure of TOLONIDINE
AGONIST -> TARGET
SHORT-ACTING
Structure of GUANABENZ
AGONIST -> TARGET
SHORT-ACTING
Structure of OXYMETAZOLINE
AGONIST -> TARGET
SHORT-ACTING
Structure of ROMIFIDINE
AGONIST -> TARGET
SHORT-ACTING
Structure of PHENTOLAMINE
AGONIST -> TARGET
SHORT-ACTING
Structure of NOREPINEPHRINE
AGONIST -> TARGET
SHORT-ACTING
Structure of MIANSERIN
AGONIST -> TARGET
SHORT-ACTING
Structure of CLONIDINE
AGONIST -> TARGET
SHORT-ACTING
Structure of MOXONIDINE
AGONIST -> TARGET
Ki
Structure of .ALPHA.-YOHIMBINE
AGONIST -> TARGET
SHORT-ACTING
Structure of CANNABIGEROL
AGONIST -> TARGET
SHORT-ACTING
Structure of ZIPRASIDONE
AGONIST -> TARGET
SHORT-ACTING
Structure of DEXMEDETOMIDINE
AGONIST -> TARGET
SHORT-ACTING
Structure of METHAMPHETAMINE
AGONIST -> TARGET
SHORT-ACTING
Structure of LOFEXIDINE
AGONIST -> TARGET
SHORT-ACTING
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT CHEMICAL
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966